Ann Taylor upgraded at JefferiesANN was upgraded from Underperform to Hold, Jefferies said. $20 price target. Turnaround continues, because of a stronger product offering.
Blackrock downgraded at DeutscheBLK was downgraded from Buy to Hold, Deutsche Bank said. Margin growth could be constrained, as the company sees lower asset inflows. $235 price target.
Cummins rated new Buy at Morgan JosephCMI was initiated with a Buy rating, Morgan Joseph said. $75 price target. Company has attractive growth prospects over the next few years.
Dreamworks Animation downgraded at Morgan StanleyDWA was downgraded to Underweight, Morgan Stanley said. Latest movie has been disappointing so far, and the stock could lag other media names that have advertising exposure. $35 price target.
Foot Locker upgraded at FBRFL was upgraded to Outperform, FBR Capital Markets said. $17 price target. Comp sales are improving and the company is expanding overseas.
Gap rated new Buy at SuntrustGPS was initiated with a Buy rating, Suntrust Robinson Humphrey said. $28 price target. Sales trends should soon begin to accelerate.
Human Genome rated new Buy at Collins StewartHGSI was initiated with a Buy rating, Collins Stewart said. $37 price target. Firm has emerged as a core mid-cap holding.
Janus upgraded at KBWJNS was upgraded from Market Perform to Outperform, Keefe, Bruyette & Woods said. $17.75 price target. Industry saw solid inflows in the first quarter.
Legg Mason upgraded at KBWLM was upgraded from Market Perform to Outperform, Keefe, Bruyette & Woods said. $37 price target. Asset management stocks are attractively valued, as inflows should remain strong.
Omnicare upgraded at UBSOCR was upgraded from Neutral to Buy, UBS said. $36 price target. Company generates strong cash flow and now longer faces the upper limit reimbursement risk.
Research in Motion numbers raised at UBSShares of RIMM now seen reaching $75, according to UBS. Estimates also increased, as the company is seeing better unit sales and gross margin. Neutral rating.
Research in Motion downgraded at GoldmanRIMM was downgraded from Neutral to Sell, Goldman Sachs said. $65 price target. Estimates could continue to trend lower, because of pricing.
Under Armour upgraded at WedbushUA was upgraded from Underperform to Neutral, Wedbush Morgan said. $31 price target. New analyst believes that the company can gain market share, but already appears fully priced.
Shares of CSCO now seen reaching $28, UBS said. Estimates also increased, given positive industry demand trends. Neutral rating.
Dollar General price target higher at Barclays
DG price target increased by a dollar to $29. The company continues to have many opportunities to boost its gross margin. Maintain Overweight rating. 2010 EPS estimate set at $1.61.
Dollar General price target higher at BarclaysDG price target increased by a dollar to $29. The company continues to have many opportunities to boost its gross margin. Maintain Overweight rating. 2010 EPS estimate set at $1.61.
Dollar General estimates raised at Morgan StanleyDG estimates were upped through 2011, Morgan Stanley said. Company should be able to keep driving margin growth over the coming quarters. Overweight rating and $30 price target.
Family Dollar numbers raised at GoldmanShares of FDO now seen reaching $33, according to Goldman Sachs. Estimates also increased, as the company should see further gross margin expansion.
Global Payments numbers upped at GoldmanShares of GPN now seen reaching $52, according to Goldman Sachs. Estimates also increased, given new currency assumptions. Neutral rating.
Intercontinental Exchange numbers upped at UBSShares of ICE now seen reaching $128, according to UBS. Estimates also boosted, because of strong futures volumes. Buy rating.
Macy's estimates, target increased at GoldmanM estimates were boosted through 2012, Goldman Sachs said. Company is paying down debt, which will cut interest costs. Neutral rating and new $22 price target.
Micron Technology target boosted at Credit SuisseMU price target jumped to $20 from $15 on strong 2Q10 results, Credit Suisse said. 2010 and 2011 EPS estimates jumped to $1.50 and $2.45, respectively. Maintain Outperform rating.
Micron estimates boosted at UBSMU estimates were raised through 2011, UBS said. Company continues to benefit from higher DRAM prices, but low supply could ultimately hurt earnings growth. Neutral rating and $10.50 price target.
Office Depot estimates raised at GoldmanODP estimates were increased through 2012, Goldman Sachs said. Paying cash for the preferred dividend will reduce dilution. Neutral rating and $8 price target.
Overstock.com estimates lowered at Morgan StanleyOSTK estimates were reduced through 2012, Morgan Stanley said. Company is struggling to balance sales growth with profitability. Underweight rating.
Rite Aid estimates cut at Morgan StanleyRAD estimates were lowered through 2012, Morgan Stanley said. Company is seeing poor results across the board and has limited visibility.
Research in Motion estimate higher at Barclays RIMM 2011 EPS estimate jumped to $5.30 from $5.08 on strong guidance, Barclays said. Maintain Overweight rating and $85 price target.
Target numbers boosted at GoldmanShares of TGT now seen reaching $53, Goldman Sachs said. Estimates also raised, because of improving credit trends. Neutral rating.
